Analysis of pharmacogenetic traits in two distinct South African populations - Wikidata - wikimedia - TriplyDB

Analysis of pharmacogenetic traits in two distinct South African populations

Analysis of pharmacogenetic traits in two distinct South African populations

http://www.wikidata.org/entity/Q36475143

about

Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals Genetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South Africa Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation.Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients.An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.Characterization of the genetic variation present in CYP3A4 in three South African populations.CYP2B6*6 and CYP2B6*18 Predict Long-Term Efavirenz Exposure Measured in Hair Samples in HIV-Positive South African Women Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.Cytochrome P450 pharmacogenetics in African populations.Priority pharmacogenetics for the African continent: focus on CYP450.Cytochrome P450 pharmacogenetics in African populations: implications for public health.Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs.Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.Evaluation of predictiveCYP2C19genotyping assays relative to measured phenotype in a South African cohort

P2860

Q28069383-BC13DDF7-765E-4D7B-A212-2AA4F60A0BA5 Q33890370-AA6CAA29-4A30-4357-808E-1C5AE694F80B Q34565428-D4A4F672-FBB8-4361-9A85-76BE4FFDF7B3 Q35584999-7E529D06-8443-420F-9BA4-B0374A2E8A79 Q36074119-4EC126DA-59CF-4478-9DCF-268FE77F38E6 Q36370484-E47A1C79-F86A-49DC-BD8F-CAB3CE44E16A Q36437792-2790F168-0238-4CA5-B3A9-FCA73788E9A9 Q36468872-F5E11A25-58FE-4633-ADFC-1442F319C437 Q36617170-A12706D1-7C25-4D68-B0EF-805383569DF3 Q36966640-D8433263-BD3E-4BF3-BA08-FBBC55C7EBF9 Q36973336-036AFDC1-E287-4ED3-A0AD-71C4F700D1D7 Q38099372-50044759-2A92-435E-B45C-ADA5C7BAB861 Q38188600-0724BF8B-86AF-455E-BB1F-056C25C03739 Q38192688-C8A36CFE-D5B0-46B5-BB46-367F163E21AF Q38267710-6FBA8A3E-EFD8-46CA-B80C-3E7DE499DF1A Q38957969-7FD235F8-BD3F-4829-94D2-6C91B8404386 Q43879115-6A09AE2C-2F94-46C3-B97F-AA68E1810D43 Q44502093-07DC5345-B00F-40E2-AA5A-DAC331476412 Q47906608-7C20A631-CE50-4700-A0B0-780AD1E67762 Q59205492-93081473-D8D9-4B96-8336-9E5C1876FA44

P2860

Analysis of pharmacogenetic traits in two distinct South African populations

http://www.wikidata.org/entity/Q36475143

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Analysis of pharmacogenetic traits in two distinct South African populations

@ast

Analysis of pharmacogenetic traits in two distinct South African populations

@en

type

label

Analysis of pharmacogenetic traits in two distinct South African populations

@ast

Analysis of pharmacogenetic traits in two distinct South African populations

@en

prefLabel

Analysis of pharmacogenetic traits in two distinct South African populations

@ast

Analysis of pharmacogenetic traits in two distinct South African populations

@en

P1433

Q36475143-4A9F19D8-9C87-440C-9ACC-29185041E0E3

P1476

Q36475143-820F6E3C-3BD3-4E3B-9843-09F81DBA6775

P2093

Q36475143-2FBF2944-C7B5-4492-8F0F-DD2B5CC17FC2

Q36475143-6B51FA90-0FE6-4ECC-8168-3008F05DD013

Q36475143-7FAF22F7-D4F4-4159-9DA9-2E25BA416513

Q36475143-829C8DAE-D162-4B28-832C-222E3FD8088B

Q36475143-EBA94959-2A1D-49A6-B16B-FC656212A535

P2860

Q36475143-04533FB7-8951-4D39-80F9-55A0CD0A8556

Q36475143-086DD1A2-EE64-4A7A-82C0-8EA57A9E2874

Q36475143-14166084-68F6-43FB-BF2F-DC6CD4186B9D

Q36475143-29A248C1-3190-4297-90E7-6CF27795A497

Q36475143-2DAB17E5-ADB9-4275-9706-1EB65A2F6387

Q36475143-34DB7438-267D-4DB8-B7A2-FBF6254523C3

Q36475143-3D016637-024A-4CE7-ABBF-F1C9176AB1F0

Q36475143-4810DC19-CBF2-4ED7-88B9-DD465AE6E5BA

Q36475143-52D53962-9C4F-4BE8-A31D-8428C2C67E26

Q36475143-6438CBA3-3EE1-4CCB-A792-A27B2FE58B85

P2888

Q36475143-61682903-104E-4A58-A28D-84C719F5D14B

P304

Q36475143-1068BCDA-E00E-4CF6-A214-8827E6C4909A

P31

Q36475143-EA27B86E-8B58-4900-A72D-CBF16AA8EA1D

P356

Q36475143-444EE48B-1721-4F73-A5CA-0DA34AFCD7FF

P433

Q36475143-6A81DDA4-8A17-4A1A-8404-007DA88DA6D3

P478

Q36475143-0FA1AC55-9B9F-4AC2-B6A6-271157CAA984

P50

Q36475143-42AADCA2-EDF9-4B1F-A7DF-67249950C85D

P577

Q36475143-CDDEEA3F-6394-40E9-BAA6-BEE04AA3251C

P5875

Q36475143-B11E27F5-D324-4F07-A7BF-808B46F90B45

P6179

Q36475143-0B855F67-1505-45DE-9F02-4981FAC4D8A2

P698

Q36475143-E9C09C61-D079-42D9-AF5D-D6F2D195E619

P921

Q36475143-025C7ABB-E6D2-412E-90D6-32B31D618C9C

P932

Q36475143-440ACFFD-CDA2-40D9-8C36-3A400E7C6DE0

P356

1479-7364-5-4-265

P1433

P1476

Analysis of pharmacogenetic traits in two distinct South African populations

@en

P2093

Bradley Aouizerat

http://www.w3.org/2001/XMLSchema#string

Monica Gandhi

http://www.w3.org/2001/XMLSchema#string

Ogechi Ikediobi

http://www.w3.org/2001/XMLSchema#string

Stefan Gebhardt

http://www.w3.org/2001/XMLSchema#string

Yuanyuan Xiao

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic structure and history of Africans and African Americans

Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia

A simple salting out procedure for extracting DNA from human nucleated cells

Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base

A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q.

Snagger: a user-friendly program for incorporating additional information for tagSNP selection.

Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART

Addressing the challenges of the clinical application of pharmacogenetic testing

CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment

The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions

P2888

1479-7364-5-4-265

P304

265-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-7364-5-4-265

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51451092

http://www.w3.org/2001/XMLSchema#string

P6179

1047591322

http://www.w3.org/2001/XMLSchema#string

P698

21712189

http://www.w3.org/2001/XMLSchema#string

P921

Aafrikaa Kibbaa

P932

3525241

http://www.w3.org/2001/XMLSchema#string